Bevacizumab: all 1,786 studies that test it

Page 7 of 18. Open to participants first (285), then studies with results posted, then the rest; newest registration first within each.

• Study of Gamma Interfereon in Metastatic Colorectal CarcinomaCompletedNCT00786643Phase 2Results posted
• Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell CarcinomaCompletedNCT00782275Phase 2Results posted
• Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric CarcinomaCompletedNCT00780494Phase 2Results posted
• A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal CancerTerminatedNCT00779311Phase 1Results posted
• Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local TherapyCompletedNCT00776594Phase 2Results posted
• Phase II Study of Doxorubicin and Avastin® in Sarcoma.TerminatedNCT00755261Phase 2Results posted
• A Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With Chemo-naive Chronic Lymphocytic LeukemiaCompletedNCT00754650Phase 2Results posted
• Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the OvaryCompletedNCT00748657Phase 2Results posted
• Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic VitrectomyCompletedNCT00745498Not applicableResults posted
• Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung CancerCompletedNCT00741988Phase 2Results posted
• Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ AdenocarcinomaCompletedNCT00737438Phase 2Results posted
• A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)TerminatedNCT00735436Phase 2Results posted
• Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic AdenocarcinomaCompletedNCT00735306Phase 1Results posted
• Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerCompletedNCT00733408Phase 2Results posted
• Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung CancerTerminatedNCT00728845Phase 1/2Results posted
• Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00723255Phase 2Results posted
• Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast CancerCompletedNCT00723125Phase 2Results posted
• Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin LymphomaTerminatedNCT00722865Phase 2Results posted
• Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00720356Phase 2Results posted
• A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.CompletedNCT00717405Phase 2Results posted
• Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00705874Phase 1Results posted
• Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck CancerCompletedNCT00703976Phase 2Results posted
• A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.CompletedNCT00700102Phase 3Results posted
• A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal CancersCompletedNCT00698451Phase 2Results posted
• Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular EdemaCompletedNCT00682539Phase 4Results posted
• Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast CancerTerminatedNCT00679029Phase 2Results posted
• Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung CancerCompletedNCT00675597Not applicableResults posted
• Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast CancerCompletedNCT00675259Phase 2Results posted
• FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric CancerCompletedNCT00673673Phase 2Results posted
• Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)CompletedNCT00671970Phase 2Results posted
• Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast CancerCompletedNCT00670982Phase 2Results posted
• Tandutinib Plus Bevacizumab to Treat Recurrent Brain TumorsCompletedNCT00667394Phase 2Results posted
• Phase II Study of Bevacizumab (Avastin®) in MyelofibrosisTerminatedNCT00667277Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00662129Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung CancerCompletedNCT00661778Phase 2Results posted
• Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate CancerCompletedNCT00658697Phase 2Results posted
• Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung CancerCompletedNCT00655850Phase 2Results posted
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00654836Phase 2Results posted
• Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)TerminatedNCT00651482Phase 2Results posted
• Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00642759Phase 2Results posted
• Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With AvastinCompletedNCT00635050Phase 2Results posted
• A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast CancerTerminatedNCT00632541Phase 2Results posted
• Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the CervixTerminatedNCT00626561Phase 2Results posted
• A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal CancerCompletedNCT00623805Phase 3Results posted
• Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast CancerCompletedNCT00623233Phase 2Results posted
• Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of PrematurityStatus unknownNCT00622726Phase 2Results posted
• Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00621686Phase 2Results posted
• Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLCCompletedNCT00621049Phase 2Results posted
• A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast CancerCompletedNCT00618826Phase 2Results posted
• Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant SettingCompletedNCT00618657Phase 2Results posted
• Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung CancerCompletedNCT00614822Phase 2Results posted
• Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + IrinotecanCompletedNCT00613028Phase 2Results posted
• Ph II Bevacizumab + Etoposide for Pts w Recurrent MGCompletedNCT00612430Phase 2Results posted
• Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and GliosarcomasCompletedNCT00612339Phase 2Results posted
• Phase II Avastin + Bortezomib for Patients With Recurrent Malignant GliomaCompletedNCT00611325Phase 2Results posted
• Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine TumorsTerminatedNCT00609765Phase 2Results posted
• Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast CancerCompletedNCT00608972Phase 2Results posted
• Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine CarcinomaCompletedNCT00607113Phase 2Results posted
• A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.CompletedNCT00605722Phase 2Results posted
• Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)TerminatedNCT00604461Phase 1/2Results posted
• Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney CancerTerminatedNCT00601926Phase 2Results posted
• Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerCompletedNCT00601900Phase 3Results posted
• 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus BevacizumabCompletedNCT00600340Phase 3Results posted
• Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + EverolimusCompletedNCT00597506Phase 2Results posted
• Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and GliosarcomasCompletedNCT00597402Phase 2Results posted
• Treatment With Intravitreal Avastin for Large Uveal MelanomasCompletedNCT00596362Not applicableResults posted
• Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin TrialCompletedNCT00593450Phase 3Results posted
• RAD001 Plus Bevacizumab in Metastatic MelanomaCompletedNCT00591734Phase 2Results posted
• Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma MultiformeCompletedNCT00590681Phase 2Results posted
• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT00588770Phase 3Results posted
• Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial CarcinomaCompletedNCT00588666Phase 2Results posted
• Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube CancerCompletedNCT00588237Phase 2Results posted
• Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant GliomasCompletedNCT00586508Phase 2Results posted
• Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung CancerCompletedNCT00585377Phase 2Results posted
• Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer PatientsTerminatedNCT00583622Phase 2Results posted
• Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast CancerCompletedNCT00580333Phase 2Results posted
• OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.CompletedNCT00577031Phase 4Results posted
• A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver CancerCompletedNCT00576199Phase 2Results posted
• Phase II Trial for Patients With Loco-Regional Esophageal CarcinomaTerminatedNCT00570531Phase 2Results posted
• Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine TumorActive, not recruitingNCT00569127Phase 3Results posted
• Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerActive, not recruitingNCT00565851Phase 3Results posted
• Topical Avastin for Treatment of Corneal NeovascularizationCompletedNCT00559936Phase 1Results posted
• A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast CancerCompletedNCT00559845Phase 2Results posted
• Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas CancerCompletedNCT00557492Phase 2Results posted
• Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00553800Phase 2Results posted
• A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric CancerCompletedNCT00548548Phase 3Results posted
• Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical CancerCompletedNCT00548418Phase 2Results posted
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal DetachmentCompletedNCT00548197Phase 1Results posted
• Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast CancerCompletedNCT00546156Phase 2Results posted
• Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological CancersCompletedNCT00545792Phase 2Results posted
• Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal WomenCompletedNCT00545077Phase 3Results posted
• Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00541099Phase 2Results posted
• Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver InvolvementTerminatedNCT00537823Phase 2Results posted
• Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast CancerCompletedNCT00530868Phase 2Results posted
• BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerCompletedNCT00528567Phase 3Results posted
• Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or GliosarcomaCompletedNCT00525525Phase 2Results posted
• Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid TumorTerminatedNCT00523809Phase 2Results posted
• Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEUTerminatedNCT00520975Phase 3Results posted
• A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.CompletedNCT00520403Phase 2Results posted
• Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLCCompletedNCT00517595Phase 2Results posted

← Bevacizumab overview